Framework for RNA Centre of Excellence Finance and Training Consultancy

CPI are looking to establish a consultancy framework for an advisor to provide expert contribution to the technology transfer, process development, GMP Preparation and Commercial Manufacture of a self-amplifying RNA Vaccine, in response to the COVID-19 Vaccine manufacture programme. CPI requires support with management of the UK supply chain manufacture of 40 million self-amplifying RNA Vaccine doses, in response to the COVID-19 Vaccine manufacture programme.